Study Raises Doubts Over Effectiveness Of Abbott Laboratories' Rapid Coronavirus Test

Canada News News

Study Raises Doubts Over Effectiveness Of Abbott Laboratories' Rapid Coronavirus Test
Canada Latest News,Canada Headlines
  • 📰 Forbes
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 53%

It represents a potential hindrance to ramping up testing in the United States.

from New York University found that Abbott Laboratories' rapid COVID-19 coronavirus test, which gives results in less than 13 minutes, missed diagnosing up to half of known positive cases, signifying a major potential hindrance to ramping up testing in the United States.... [+]

The New York University Langone School of Medicine study, which hasn't been peer-reviewed yet, compared the rapid test to one from rival Cepheid that gives results in 45 minutes.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Forbes /  🏆 394. in US

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Car rental firm Hertz raises going concern doubts as debt default loomsCar rental firm Hertz raises going concern doubts as debt default loomsHertz Global Holdings Inc on Monday raised going concern doubts as the car rental company tries to cut costs and avoid debt default amid a blow to its business due to the COVID-19 pandemic, sending its shares down 4% in extended trading.
Read more »

PayPal raises $4 billion in debt deal as business soars during pandemicPayPal raises $4 billion in debt deal as business soars during pandemicDigital payment provider PayPal raised billions in the bond market Monday, underscoring how companies that make staying at home easier are benefiting during the lockdown.
Read more »

Race for coronavirus vaccine raises eyebrows at efficacy surrounding trialsRace for coronavirus vaccine raises eyebrows at efficacy surrounding trialsHanneke Schuitemaker, Johnson & Johnson Global Head of Viral Vaccine Development, and Dr. Dara Kass, Columbia Univ. Medical Center Associate Professor, join MSNBC's Craig Melvin to discuss the efficacy surrounding various trials and where we are on the time line for an approved vaccine.
Read more »

Disney Raises $11 Billion in New DebtDisney Raises $11 Billion in New DebtThe Walt Disney Co. has raised nearly $11 billion in a new debt offering amid the novel coronavirus pandemic. More details:
Read more »

Robin Hood Raises Over $115 Million Toward COVID-19 Relief and Recovery EffortsRobin Hood Raises Over $115 Million Toward COVID-19 Relief and Recovery EffortsCelebrities on the “telethon” included Tina Fey, Barbra Streisand, Sarah Jessica Parker, Lin-Manuel Miranda, Sting, Bon Jovi and Mariah Carey.
Read more »

'Rise Up NY!' Virtual Telethon Raises $115 For COVID-19 Relief'Rise Up NY!' Virtual Telethon Raises $115 For COVID-19 Relief
Read more »



Render Time: 2025-03-16 16:59:20